Roles of growth factor activities in oncogenesis.

Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells. J Clin Invest (1990) 2.94

Sequences of the 5' portion of the human c-sis gene: characterization of the transcriptional promoter and regulation of expression of the protein product by 5' untranslated mRNA sequences. Nucleic Acids Res (1987) 1.91

Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications. J Clin Pathol (1985) 1.36

Human preleukaemia: do we have a model? Br J Cancer (1987) 1.25

Platelet-derived growth factor induces apoptosis in growth-arrested murine fibroblasts. Proc Natl Acad Sci U S A (1995) 1.10

Expression of growth factor/receptor genes in postthymic T cell malignancies. Am J Pathol (1989) 0.83

Myelodysplastic syndromes. West J Med (1989) 0.80

Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus. Nature (1983) 8.60

Amino acid sequence of human platelet factor 4. Proc Natl Acad Sci U S A (1977) 4.04

Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. Science (1987) 4.03

Chemotaxis of monocytes and neutrophils to platelet-derived growth factor. J Clin Invest (1982) 3.77

Human platelet-derived growth factor. Purification and resolution into two active protein fractions. J Biol Chem (1981) 3.21

Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci U S A (1981) 3.03

The c-sis gene encodes a precursor of the B chain of platelet-derived growth factor. EMBO J (1984) 2.77

Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms. J Cell Biol (1989) 2.54

Expression of a platelet-derived growth factor-like protein in simian sarcoma virus transformed cells. Science (1983) 2.41

Transforming protein of simian sarcoma virus stimulates autocrine growth of SSV-transformed cells through PDGF cell-surface receptors. Cell (1984) 2.41

Platelet-derived growth factor stimulates tyrosine-specific protein kinase activity in Swiss mouse 3T3 cell membranes. Proc Natl Acad Sci U S A (1982) 2.39

The Hypersensitive Reaction of Tobacco to Pseudomonas syringae pv. pisi: Activation of a Plasmalemma K/H Exchange Mechanism. Plant Physiol (1985) 2.33

Chemotactic activity of platelet alpha granule proteins for fibroblasts. J Cell Biol (1983) 2.28

Some kinetic properties of Bacillus subtilis glutamine synthetase. J Biol Chem (1970) 2.22

Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta. Proc Natl Acad Sci U S A (2000) 2.15

Bacillus subtilis glutamine synthetase. Purification and physical characterization. J Biol Chem (1970) 2.10

Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science (1990) 2.00

Platelet-derived growth factor. Specific binding to target cells. J Biol Chem (1982) 1.80

Transformation by v-sis occurs by an internal autoactivation mechanism. Science (1989) 1.79

Etiology of rising perfusion pressure in isolated organ perfusion. Ann Surg (1968) 1.76

Transforming growth factor beta reverses the glucocorticoid-induced wound-healing deficit in rats: possible regulation in macrophages by platelet-derived growth factor. Proc Natl Acad Sci U S A (1989) 1.73

Differential expression of pleiotrophin and midkine in advanced neuroblastomas. Cancer Res (1995) 1.72

Role of platelet-derived growth factor in wound healing. J Cell Biochem (1991) 1.69

Stimulation of in vitro human skin collagenase expression by platelet-derived growth factor. Proc Natl Acad Sci U S A (1985) 1.65

Platelet-derived growth factor elicits cyclic AMP accumulation in Swiss 3T3 cells: role of prostaglandin production. Cell (1983) 1.65

In vivo incisional wound healing augmented by platelet-derived growth factor and recombinant c-sis gene homodimeric proteins. J Exp Med (1988) 1.64

Clinical correlates of antifungal macrodilution susceptibility test results for non-AIDS patients with severe Candida infections treated with fluconazole. Antimicrob Agents Chemother (2000) 1.57

Growth factor-induced acceleration of tissue repair through direct and inductive activities in a rabbit dermal ulcer model. J Clin Invest (1991) 1.48

The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains. J Biol Chem (1993) 1.48

Platelet-derived growth factor stimulates Na+/H+ exchange and induces cytoplasmic alkalinization in NR6 cells. Proc Natl Acad Sci U S A (1983) 1.46

The Wilms' tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene. J Biol Chem (1992) 1.41

PDGF A-chain gene is expressed by mammalian neurons during development and in maturity. Cell (1991) 1.41

Platelet-derived growth factor. Structure, function, and roles in normal and transformed cells. J Clin Invest (1984) 1.38

cDNA clones reveal differences between human glial and endothelial cell platelet-derived growth factor A-chains. Nature (1987) 1.38

Platelet-derived growth factor-inducible gene JE is a member of a family of small inducible genes related to platelet factor 4. J Biol Chem (1989) 1.37

Association of bovine brain-derived growth factor receptor with protein tyrosine kinase activity. J Biol Chem (1986) 1.34

Regulation of glutamine synthetase from Bacillus subtilis by divalent cations, feedback inhibitors, and L-glutamine. J Biol Chem (1974) 1.33

Rapid turnover of the platelet-derived growth factor receptor in sis-transformed cells and reversal by suramin. Implications for the mechanism of autocrine transformation. J Biol Chem (1988) 1.31

Heparin-binding growth factor type 1 (acidic fibroblast growth factor): a potential biphasic autocrine and paracrine regulator of hepatocyte regeneration. Proc Natl Acad Sci U S A (1989) 1.29

The carboxyl-terminal tridecapeptide of platelet factor 4 is a potent chemotactic agent for monocytes. Biochem Biophys Res Commun (1982) 1.28

Mechanism of intramolecular activation of pepsinogen. Evidence for an intermediate delta and the involvement of the active site of pepsin in the intramolecular activation of pepsinogen. J Biol Chem (1976) 1.28

Intraosseous schwannoma of the fourth lumbar vertebra: case report. Neurosurgery (1998) 1.27

Host-Specific Phytotoxic Polysaccharide from Apple Tissue Infected by Erwinia amylovora. Science (1974) 1.26

A second transcriptionally active DNA-binding site for the Wilms tumor gene product, WT1. Proc Natl Acad Sci U S A (1993) 1.26

Human transforming growth factor beta.alpha 2-macroglobulin complex is a latent form of transforming growth factor beta. J Biol Chem (1988) 1.25

Specific covalent binding of platelet-derived growth factor to human plasma alpha 2-macroglobulin. Proc Natl Acad Sci U S A (1984) 1.24

Pleiotrophin transforms NIH 3T3 cells and induces tumors in nude mice. Proc Natl Acad Sci U S A (1993) 1.22

Platelet-derived growth factor promotes human peripheral monocyte activation. Blood (1985) 1.19

Platelet-derived growth factor stimulates the phosphorylation of ribosomal protein S6. FEBS Lett (1983) 1.18

Cathepsin D isozymes from porcine spleens. Large scale purification and polypeptide chain arrangements. J Biol Chem (1979) 1.18

Sensitive assay for cellulase and dextranase. Anal Biochem (1976) 1.17

Bacillus subtilis glutamine synthetase. Specific catalytic changes associated with limited sulfhydryl modification. J Biol Chem (1971) 1.17

Upregulation of pleiotrophin gene expression in developing microvasculature, macrophages, and astrocytes after acute ischemic brain injury. J Neurosci (1998) 1.15

Reversal of human immunodeficiency virus type 1-associated hematosuppression by effective antiretroviral therapy. Clin Infect Dis (2000) 1.14

The type V transforming growth factor beta receptor is the putative insulin-like growth factor-binding protein 3 receptor. J Biol Chem (1997) 1.14

Inhibition of the binding of low-density lipoprotein to its cell surface receptor in human fibroblasts by positively charged proteins. J Supramol Struct (1978) 1.13

A novel 17 kD heparin-binding growth factor (HBGF-8) in bovine uterus: purification and N-terminal amino acid sequence. Biochem Biophys Res Commun (1989) 1.13

Human platelet-derived growth factor: radioimmunoassay and discovery of a specific plasma-binding protein. J Cell Biol (1983) 1.12

WT1, the Wilms' tumor suppressor gene product, represses transcription through an interactive nuclear protein. Oncogene (1995) 1.11

Distribution of decane within the unit cell of the inverted hexagonal (HII) phase of lipid-water-decane systems determined by neutron diffraction. Biochemistry (1992) 1.11

Antimicrobial activity of honokiol and magnolol isolated from Magnolia officinalis. Phytother Res (2001) 1.10

Platelet-derived growth factor induces apoptosis in growth-arrested murine fibroblasts. Proc Natl Acad Sci U S A (1995) 1.10

The amino acid sequence of cobrotoxin. Biochim Biophys Acta (1969) 1.09

Human breast cancer growth inhibited in vivo by a dominant negative pleiotrophin mutant. J Biol Chem (1997) 1.09

Prediction of recurrent choledocholithiasis by quantitative cholescintigraphy in patients after endoscopic sphincterotomy. Gut (1997) 1.09

Platelet-derived growth factor promotes polymorphonuclear leukocyte activation. Blood (1984) 1.08

Amidation of saturated C-H bonds catalyzed by electron-deficient ruthenium and manganese porphyrins. A highly catalytic nitrogen atom transfer process. Org Lett (2000) 1.08

Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices. Hepatology (1997) 1.08

Pleiotrophin disrupts calcium-dependent homophilic cell-cell adhesion and initiates an epithelial-mesenchymal transition. Proc Natl Acad Sci U S A (2006) 1.07

Proteoglycan carrier of human platelet factor 4. Isolation and characterization. J Biol Chem (1982) 1.06

New synthesis of a platelet-specific protein: platelet factor 4 synthesis in a megakaryocyte-enriched rabbit bone marrow culture system. J Cell Biol (1983) 1.06

Antimicrobial activity of tannin components from Vaccinium vitis-idaea L. J Pharm Pharmacol (2001) 1.06

Ultrastructural localization of a platelet-derived growth factor/v-sis-related protein(s) in cytoplasm and nucleus of simian sarcoma virus-transformed cells. Proc Natl Acad Sci U S A (1987) 1.06

Correlation of serum immunoglobulin G Helicobacter pylori antibody titers with histologic and endoscopic findings in patients with dyspepsia. J Clin Gastroenterol (1997) 1.06

Observation of a charged charmoniumlike structure in e+ e- → π+ π- J/ψ at sqrt[s] = 4.26  GeV. Phys Rev Lett (2013) 1.05

Purification and characterization of the neu/erb B2 ligand-growth factor from bovine kidney. J Biol Chem (1992) 1.05

Pleiotrophin and midkine, a family of mitogenic and angiogenic heparin-binding growth and differentiation factors. Curr Opin Hematol (1999) 1.05

Interactions of high affinity insulin-like growth factor-binding proteins with the type V transforming growth factor-beta receptor in mink lung epithelial cells. J Biol Chem (1999) 1.04

Platelet-derived growth factor (PDGF) receptor-alpha activates c-Jun NH2-terminal kinase-1 and antagonizes PDGF receptor-beta -induced phenotypic transformation. J Biol Chem (2000) 1.04

Bilateral macular coloboma and pigmented paravenous retinochoroidal atrophy. Br J Ophthalmol (1992) 1.03

Serum lactate dehydrogenase level in patients with nasopharyngeal carcinoma. Acta Oncol (1997) 1.03

A phase II study to evaluate recombinant platelet-derived growth factor-BB in the treatment of stage 3 and 4 pressure ulcers. Arch Surg (1994) 1.03

Modulation of transcription of the platelet-derived growth factor A-chain gene by a promoter region sensitive to S1 nuclease. J Biol Chem (1992) 1.02

Fluconazole disk diffusion test with methylene blue- and glucose-enriched Mueller-Hinton agar for determining susceptibility of Candida species. J Clin Microbiol (2001) 1.02